TRIB2
Basic information
Region (hg38): 2:12716910-12742734
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRIB2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 17 | 0 | 1 |
Variants in TRIB2
This is a list of pathogenic ClinVar variants found in the TRIB2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-12718345-G-A | not specified | Uncertain significance (Nov 19, 2022) | ||
2-12718363-A-G | not specified | Uncertain significance (Jul 11, 2022) | ||
2-12718368-A-G | not specified | Uncertain significance (Feb 13, 2024) | ||
2-12718369-C-G | not specified | Uncertain significance (Dec 13, 2023) | ||
2-12718383-G-C | not specified | Uncertain significance (Jun 03, 2022) | ||
2-12718385-G-C | not specified | Uncertain significance (Sep 16, 2021) | ||
2-12718395-A-G | not specified | Uncertain significance (Nov 21, 2022) | ||
2-12718401-T-A | not specified | Uncertain significance (Aug 17, 2022) | ||
2-12718486-G-C | not specified | Uncertain significance (Dec 05, 2022) | ||
2-12718513-C-A | not specified | Uncertain significance (Feb 27, 2024) | ||
2-12718537-G-A | not specified | Uncertain significance (Nov 09, 2023) | ||
2-12718542-G-C | not specified | Uncertain significance (Nov 08, 2022) | ||
2-12723293-G-T | not specified | Uncertain significance (Jul 09, 2021) | ||
2-12723315-C-A | not specified | Uncertain significance (Apr 23, 2024) | ||
2-12723545-G-A | not specified | Uncertain significance (May 30, 2024) | ||
2-12723562-A-T | Benign (Jul 04, 2018) | |||
2-12740393-G-A | not specified | Uncertain significance (Feb 12, 2024) | ||
2-12740417-G-A | not specified | Uncertain significance (Sep 07, 2022) | ||
2-12740534-G-A | not specified | Uncertain significance (Feb 28, 2024) | ||
2-12740634-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
2-12740702-G-A | not specified | Uncertain significance (Mar 23, 2022) | ||
2-12740717-T-C | not specified | Uncertain significance (Apr 29, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRIB2 | protein_coding | protein_coding | ENST00000155926 | 3 | 25846 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.983 | 0.0165 | 125713 | 0 | 1 | 125714 | 0.00000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.71 | 141 | 211 | 0.669 | 0.0000128 | 2253 |
Missense in Polyphen | 35 | 85.938 | 0.40727 | 883 | ||
Synonymous | -0.0617 | 93 | 92.2 | 1.01 | 0.00000578 | 692 |
Loss of Function | 3.27 | 0 | 12.5 | 0.00 | 7.02e-7 | 141 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000879 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Interacts with MAPK kinases and regulates activation of MAP kinases. Does not display kinase activity (By similarity). {ECO:0000250|UniProtKB:Q28283, ECO:0000250|UniProtKB:Q96RU8}.;
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- 0.0468
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 34.32
Haploinsufficiency Scores
- pHI
- 0.226
- hipred
- Y
- hipred_score
- 0.768
- ghis
- 0.542
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.834
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trib2
- Phenotype
- growth/size/body region phenotype; immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein phosphorylation;negative regulation of protein kinase activity;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;regulation of MAP kinase activity;negative regulation of interleukin-10 biosynthetic process;negative regulation of fat cell differentiation
- Cellular component
- nucleus;cytoplasm;cytoskeleton
- Molecular function
- nucleotide binding;protein kinase activity;protein kinase inhibitor activity;transcription factor binding;mitogen-activated protein kinase kinase binding;ubiquitin protein ligase binding;ubiquitin-protein transferase regulator activity